Luminar Technologies Azioni (NASDAQ: LAZR)

Luminar Technologies (NASDAQ:LAZR) Azioni

Luminar Technologies

Luminar Technologies Inc is an automotive technology company ushering in a new era of vehicle safety and autonomy. It operates its business through the following segments: Autonomy Solutions and advanced Technologies and Services. The majority of revenue is earned from the Autonomy Solutions segment which engaged in the design, manufacturing, and sale of LiDAR sensors catering mainly to the OEMs in the automobile, commercial vehicle, robo-taxi, and adjacent industries and advanced Technologies and Services provides semiconductors and related components, as well as design, test and consulting services to the Autonomy Solutions segment and various third-party customers, including government agencies and defense contractors, in markets generally unrelated to autonomous vehicles.

matrix-2953883

News

LAZR

Dopo un trimestre oltre le aspettative, il titolo del settore auto-tech registra un&#39;impennata significativa.

Oltre le aspettative: LAZR sbalordisce con i risultati del Q4 e sale del 55%

Luminar Technologies, Inc. - Class A Common Stock

Luminar Technologies Inc

Management

Fiserv Appoints Takis Georgakopoulos As COO

Earnings

CENN

Cenntro FY24 Revenue $31.3M Up From $10.4M YoY

Redburn Atlantic analyst Jamie Clark initiates coverage on Labcorp Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LH#NYSE">LH</a>) with a Buy rating and announces Price Target of $276.

Price Target

Initiation

Analyst Ratings

Laboratory Corporation Of America Holdings

Redburn Atlantic Initiates Coverage On Labcorp Hldgs with Buy Rating, Announces Price Target of $276

B of A Securities analyst Ebrahim Poonawala maintains State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) with a Underperform and raises the price target from $98 to $99.

B of A Securities Maintains Underperform on State Street, Raises Price Target to $99

Good Morning Traders! In today&#8217;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.
We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#8217;s pulse to optimize your trading gains. Now, let&#8217;s dive into the stock analysis:
SPDR S&amp;P 500 ETF Trust (SPY)
Bulls will want SPY to firmly reclaim and hold the initial auction point of 557.44. Sustained strength here should prompt an upward test towards 558.32, with buyers targeting further momentum toward 559.75. A successful consolidation at this higher pivot would suggest bullish continuation aiming next for 560.83, ultimately stretching towards today&#8217;s bullish extreme at 561.90.
Conversely, failure to defend 557.44 invites sellers to press downwards initially to challenge 556.27. Persistent bearish activity here would likely expose the next downside target at 555.11. If selling intensifies below this mark, look for a critical test of 553.66, with today&#8217;s maximum bearish extent positioned firmly lower at 552.50.
Invesco QQQ Trust Series 1 (QQQ)
The bulls on QQQ must quickly reclaim and maintain a supportive base above today&#8217;s pivotal level of 469.27. If buying volume persists here, traders can expect further advancement to challenge resistance at 471.33. Continued bullish sentiment would then push price upwards to 474.66, with a potential acceleration higher to 476.85, finally eyeing today&#8217;s upper bull target at 479.03.
If QQQ demonstrates weakness below 469.27 during normal trading hours, bears will aggressively seek to take control, testing lower support at 467.60. Sellers could extend declines further to 465.93, and sustained downward momentum would likely invite a deeper probe at 463.56. Breaking this level decisively opens the path toward today&#8217;s bearish limit at 462.14.
Apple Inc. (AAPL)
Apple bulls need to maintain price stability above the initial auction level of 222.24. Successful buying here could lead to a drive higher, first testing resistance at 222.96. Persistent bullish interest would likely push Apple further upward to 223.87, ultimately targeting today&#8217;s highest bullish scenario at 225.31.
However, should Apple weaken and lose support at 222.24, expect bearish pressure to push the price initially towards 221.66. Continued selling activity might extend losses down to 220.97, with deeper bearish sentiment bringing 220.29 into focus. If sellers dominate, expect the price to decline further towards today&#8217;s bearish extreme at 219.19.
Microsoft Corp. (MSFT)
Microsoft&#8217;s bullish traders should defend and maintain strength above today&#8217;s critical pivot of 380.59. Sustained bullish pressure at this mark could initiate an upward rally to test 381.64, which bulls need to secure as support. Holding above here could trigger a move higher towards 382.69, ultimately targeting today&#8217;s high bull level at 384.57.
If 380.59 fails to provide solid support, expect bears to test the waters lower at 379.50. Increased bearish momentum at this level could lead to continued downside action towards 377.72. Persistent bearish control might then expose 376.70, eventually driving price down to today&#8217;s lowest bearish target of 375.93.
NVIDIA Corporation (NVDA)
NVIDIA&#8217;s bulls should aim to firmly reclaim and secure the auction above today&#8217;s key pivot of 109.12. If buyers maintain steady support, anticipate an initial bullish advance towards 109.86. Further bullish conviction may lead the price toward the next resistance at 110.73, with sustained buying efforts potentially pushing NVIDIA upwards to 111.70, ultimately targeting today&#8217;s bullish peak at 112.54.
If the bulls fail to maintain control above 109.12, anticipate bearish activity initially testing support at 107.51. A decisive breakdown at this level could invite further selling, pushing price action down toward 106.30. Extended bearish dominance would likely see an important test at 105.23, with today&#8217;s bearish scenario bottoming at 103.96.
Alphabet Inc Class A (GOOGL)
For Alphabet, the bulls need to stabilize and reclaim price action above the level at 155.59, pushing upward quickly to secure 156.61 as solid support. With continued bullish pressure, expect an advance higher towards 157.41, potentially accelerating further to today&#8217;s highest bullish objective at 158.54.
A failure to maintain 155.59 would trigger bearish momentum to the downside, initially targeting support at 154.95. If sellers successfully break this level, expect an immediate bearish continuation lower to 154.44. Persistent selling pressure may lead to a deeper decline towards today&#8217;s bearish extreme target of 153.93.
Meta Platforms Inc (META)
Meta&#8217;s bullish traders must promptly defend and maintain price strength above today&#8217;s pivotal auction level at 580.17. If bullish strength remains persistent, expect an initial upward drive to resistance at 585.73. Sustained bullish momentum may extend further upward toward 591.29, ultimately aiming for today&#8217;s maximum bullish potential at 598.17.
Should bulls falter and lose control of 580.17, bears will quickly attempt to take advantage, pressing price downward toward the next support at 573.25. Sustained selling pressure here would further weaken the price towards 565.53. Continued bearish dominance could push Meta even lower, eventually hitting today&#8217;s low bear target at 559.29.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)
Tesla bulls need immediate strength to secure the initial auction level of 262.68. If bullish demand emerges strongly here, price action may quickly ascend toward resistance at 264.46. Continued bullish activity could then propel Tesla higher to 266.83, with the potential for an extended rally to 269.48. If buyers dominate today, watch for Tesla reaching today&#8217;s bullish target at 272.42.
If buyers fail to defend 262.68, bearish traders will aggressively press downward, testing initial support at 259.81. Further bearish control would likely push the auction lower to 257.56. A definitive bearish breakdown here could extend losses further down toward today&#8217;s ultimate bearish scenario at 256.34.
Final Word:&nbsp;
Today&#8217;s session begins with crucial economic indicators, starting with March&#8217;s ADP Non-Farm Employment Change at 8:15AM ET, an influential preview ahead of Friday's official jobs report. Following this, at 10AM ET, markets receive February's Factory Orders and the finalized Durable Goods Orders, both vital measures of industrial demand and economic momentum. Lastly, investors must brace for potential volatility at 3PM ET, before President Trump announces key tariff decisions that could significantly sway market sentiment.
Given the critical economic data and policy announcements lined up today, anticipate substantial market volatility and elevated risk. Traders should remain vigilant, maintain disciplined strategies, and prioritize risk management to navigate potential sharp market moves effectively. Good luck and trade safely!
The Morning Memo is curated by RIPS, a pro trader with years of experience in equities, options, and futures trading. RIPS is at the heart of the exclusive Market Clubhouse community, offering his insights, expertise, and real-time mentorship.
Start your day with a live daily market analysis, a carefully selected watch list, early access to the Morning Memo, and exclusive Market Clubhouse price levels, providing precise support and resistance indicators. When you become a member of Market Clubhouse, you will gain early access to the Morning Memo, just like this one, every single day—hours before it&#8217;s published. You will also have access to a live stream with zero latency and screen sharing, enabling you to witness Rips executing his trades in real-time and sharing his exclusive trading plans, strategies, and live decision-making.
For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.

Equities

Broad U.S. Equity ETFs

Technicals

Opinion

Signals

Trading Ideas

TSLA

How To Trade SPY, As Market Braces For Trump's Tariffs Plan

-ReutersAdvances Company's industry-leading portfolio in mental health with addition of CAPLYTA&#xAE; (lumateperone), the first and only U.S. FDA-approved treatment for bipolar I and II depression as an adjunctive therapy and monotherapy; also approved for the treatment of schizophrenia in adults
sNDA submitted to U.S. FDA for CAPLYTA&#xAE; as adjunctive treatment for major depressive disorder; if approved, has potential to become a new standard of care for most common depressive disorders
Addition of CAPLYTA&#xAE; strengthens J&amp;J's robust lineup of therapies with $5 billion+ potential in peak year salesi, further solidifying sales growth above analyst expectations now through the remainder of the decade
Acquisition also includes promising clinical-stage pipeline with best-in-class potential in generalized anxiety disorder and Alzheimer's disease-related psychosis and agitation
Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) today announced it has completed its acquisition of Intra-Cellular Therapies, Inc. Intra-Cellular Therapies is now part of Johnson &amp; Johnson and will operate as a business unit within Johnson &amp; Johnson Innovative Medicine.
"At Johnson &amp; Johnson, we are committed to transforming care for the millions of people worldwide living with neuropsychiatric and neurodegenerative disorders," said Joaquin Duato, Chairman and Chief Executive Officer, Johnson &amp; Johnson. "We are excited to officially welcome the talented Intra-Cellular Therapies team to the Company, and we look forward to working together as we realize our ambition of becoming the number one neuroscience company worldwide."
With this acquisition, Johnson &amp; Johnson adds CAPLYTA&#xAE; (lumateperone) to its robust portfolio of differentiated medicines. CAPLYTA&#xAE; is a once-daily oral therapy approved to treat adults with schizophrenia, as well as the first and only U.S. Food and Drug Administration (FDA)-approved treatment for depressive episodes associated with bipolar I or II disorder (bipolar depression), as a monotherapy and adjunctive therapy with lithium or valproate. In February 2025, Intra-Cellular Therapies announced that the U.S. FDA accepted its supplemental new drug application for CAPLYTA&#xAE; as an adjunctive treatment for adults with major depressive disorder (MDD). The acquisition also includes ITI-1284, a promising Phase 2 compound being studied in generalized anxiety disorder (GAD) and Alzheimer's disease-related psychosis and agitation, as well as a clinical-stage pipeline that further complements Johnson &amp; Johnson's current areas of focus.
"We are focused on investing in what we believe is the future of innovation across our targeted therapeutic areas, including neuroscience," said Jennifer Taubert, Executive Vice President, Worldwide Chairman, Innovative Medicine, Johnson &amp; Johnson. "We are pleased to finalize this acquisition, which serves as a strategic near- and long-term growth catalyst for Johnson &amp; Johnson, and we look forward to working together to continue transforming treatment and patient care for some of today's most debilitating neuropsychiatric and neurodegenerative disorders."

Johnson & Johnson Closes Intra-Cellular Therapies Acquisition; Expects Deal To Dilute Adj EPS By ~$0.25 in 2025

Redburn Atlantic analyst Jamie Clark initiates coverage on Quest Diagnostics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DGX#NYSE">DGX</a>) with a Buy rating and announces Price Target of $195.

Redburn Atlantic Initiates Coverage On Quest Diagnostics with Buy Rating, Announces Price Target of $195

Initial 500MWh capacity of ~$100 million to be delivered under equipment contracts by Energy Vault over the next 12 months during the local Indian manufacturing build out, and expected to ramp over the next 10 years to 30-40+ GWh
SPML Infra, one of India's largest and longest running urban infrastructure developers of water treatment, solid waste management and clean energy assets, perfectly positioned to minimize import tariffs with local manufacturing capabilities and to manufacture and deploy Energy Vault's B-VAULT&#x2122; battery energy storage system (BESS) technology, along with VaultOS&#x2122; energy storage management (EMS) software
Agreement will have positive revenue, gross margin and cash impact in Q1 and Q2 2025 for Energy Vault from the initial License portion of the contact; in addition to the 500MWh in battery deliveries from Energy Vault, the terms include multi-year license revenues and volume-based royalty revenue streams tied to project deployments in India
Manufacturing localization and deep infrastructure market expertise of SPML expected to deliver industry-leading cost efficiencies and competitiveness in India's growing energy storage market

Contracts

NRGV

Energy Vault Signed New Licensing And Royalty Agreement With SPML Infra With Specific Focus On India's Water And Energy Infrastructure.

WIIM

YOSH

Yoshiharu Global shares are trading higher after the company reported a year-over-year increase in Q4 revenue results.

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARTL#NASDAQ">ARTL</a>) with a Buy and maintains $6 price target.

ARTL

D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $6 Price Target

SPWH

Sportsman's Warehouse Holdings shares are trading higher after the company reported better-than-expected Q4 financial results.

ALLK

Allakos shares are trading higher after the company announced it entered into an agreement to be acquired by Concentra Biosciences for $0.33 per share in cash.

Ryanair Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAAY#NASDAQ">RYAAY</a>) announced on Wednesday that it flew <a target="_blank" href="https://corporate.ryanair.com/news/first-european-airline-to-carry-200m-passengers-in-one-year/" rel="noreferrer noopener">200.2 million passengers</a> in the year ending March 2025, marking a 9% year-over-year increase and becoming the first European airline to carry 200 million passengers in a single year.
For the month ending March 31, passenger traffic rose 10% year-over-year to 15 million, with a load factor of 93%, unchanged from the previous year.
On March 27, Ryanair celebrated this <a target="_blank" href="https://corporate.ryanair.com/news/record-200m-passengers-choose-ryanairs-low-fares/?market=en" rel="noreferrer noopener">milestone</a> by naming 84-year-old Maria Cornelia Vos—who flew from Fuerteventura to Madrid on March 26—its 200 millionth passenger.
Ryanair CEO Michael O&#8217;Leary commented, &#8220;We are delighted to welcome Mrs. Maria Cornelia Vos as our 200 millionth passenger this year. Ryanair is proud to have carried 200 million passengers in 2024/2025, and we&#8217;re pleased that they collectively saved an estimated €5 billion compared to the average airfares of our competitors.&#8221;
In January, the airline <a target="_blank" href="https://www.benzinga.com/25/01/43231427/ryanairs-q3-revenue-surges-10-despite-boeing-delays-provides-promising-outlook" rel="noreferrer noopener">projected</a> that FY25 traffic would reach nearly 200 million passengers—representing 9% growth—assuming no further disruptions from Boeing delivery delays.
In another development, Ryanair recently <a target="_blank" href="https://corporate.ryanair.com/news/ryanair-celebrates-10-years-of-operations-at-copenhagen-with-new-summer-2025-schedule/" rel="noreferrer noopener">marked </a>10 years of operations in Copenhagen with the launch of its Summer 2025 schedule, which includes over 360 weekly flights and an extended Barcelona route. With four aircraft based in the city and a $400 million investment, the airline supports more than 2,300 local jobs.
Price Action: RYAAY shares are trading higher by 0.77% at $43.00 premarket on the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com//node/44605165" target="_blank" rel="noreferrer noopener">Tesla&#8217;s March Slump Stands Out As Competitors Surge Amid Tariff-Driven Rush</a></li>
</ul>
Image via Shutterstock.

Travel

General

RYAAY

Ryanair Soars Past 200 Million Passengers In One Year, Sets New European Record In Air Travel

HC Wainwright &amp; Co. analyst Robert Burns reiterates Nurix Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NRIX#NASDAQ">NRIX</a>) with a Buy and maintains $36 price target.

Reiteration

NRIX

HC Wainwright & Co. Reiterates Buy on Nurix Therapeutics, Maintains $36 Price Target

CRBG

Corebridge Financial shares are trading lower after UBS downgraded the stock from Buy to Sell and cut its price target from $40 to $28.

William Blair analyst Robert Napoli downgrades Ncino (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCNO#NASDAQ">NCNO</a>) from Outperform to Market Perform.

Downgrades

NCNO

William Blair Downgrades Ncino to Market Perform

Stephens &amp; Co. analyst Jim Salera reiterates Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) with a Equal-Weight and maintains $440 price target.

Stephens & Co. Reiterates Equal-Weight on Domino's Pizza, Maintains $440 Price Target

NMAX

Newsmax shares are trading lower. The stock may be reversing after rising this week when commencing an IPO.

Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>) will release its third-quarter earnings results before the <a href="https://www.benzinga.com/quote/CAG/earnings">opening bell on Thursday, April 3.</a>
Analysts expect the Chicago-based company to report quarterly earnings at 53 cents per share, down from 69 cents per share in the year-ago period. According to data from Benzinga Pro, Conagra projects quarterly revenue at $2.9 billion, compared to $3.03 billion a year earlier.
Conagra Brands announced on Tuesday that it&#8217;s teaming up with Bloom Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) to integrate advanced fuel cell technology at two of its Ohio manufacturing plants.
With the recent buzz around Conagra Brands, some investors may be eyeing potential gains from the company's dividends, too. Conagra Brands currently offers an annual dividend yield of 5.26% and a quarterly dividend of 35 cents per share ($1.40 a year).  
So, how can investors exploit its dividend yield to pocket a regular $500 monthly?
To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $114,008 or around 4,286 shares. For a more modest $100 per month or $1,200 per year, you would need $22,796 or around 857 shares.
To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($1.40 in this case). So, $6,000 / $1.40 = 4,286 ($500 per month), and $1,200 / $1.40 = 857 shares ($100 per month).
Note that dividend yield can change on a rolling basis as the dividend payment and stock price fluctuate over time.
How that works: The dividend yield is computed by dividing the annual dividend payment by the stock&#8217;s current price.
For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).
Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.
CAG Price Action: Shares of Conagra fell 0.3% to close at $26.60 on Tuesday.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/04/44584246/wall-streets-most-accurate-analysts-give-their-take-on-3-consumer-stocks-delivering-high-dividend-yields-6">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Consumer Stocks Delivering High-Dividend Yields</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Markets

How To Earn $500 A Month From Conagra Brands Stock Ahead Of Q3 Earnings

CNTM

ConnectM Technology Solutions shares are trading higher after the company announced it received a $1.60 per share buyout offer from 3 institutional investors.

Comments

Luminar Technologies

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO